| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Collins Cooper C. is a Director at TXMD. Recent filings cover 9 purchases and 0 sales.
Our model assigns Collins Cooper C. a below-average insider score of 19/100, based on 5 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -60.2%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2024 | TXMD Therapeuticsmd, Inc. | - | Buy | 4,094 | $1.73 | $7,099.00 | +8.5% | -23.4% | -37.1% | |
| Aug 21, 2024 | TXMD Therapeuticsmd, Inc. | - | Buy | 1,200 | $1.70 | $2,038.56 | +2.6% | -22.8% | -35.9% | |
| Nov 18, 2021 | TXMD Therapeuticsmd, Inc. | Director | Buy | 1,000,000 | $0.58 | $578,500.00 | +80.8% | -55.2% | -82.7% | |
| Aug 18, 2021 | TXMD Therapeuticsmd, Inc. | Director | Buy | 1,000,000 | $0.73 | $725,000.00 | +422.2% | -18.3% | -71.6% | |
| Jun 9, 2020 | TXMD Therapeuticsmd, Inc. | Director | Buy | 74,000 | $1.45 | $107,300.00 | +112.1% | - | - | |
| May 13, 2019 | TXMD Therapeuticsmd, Inc. | Director | Buy | 30,000 | $3.33 | $99,870.00 | +83.3% | - | - | |
| Mar 11, 2016 | TXMD Therapeuticsmd, Inc. | Director | Buy | 16,000 | $6.23 | $99,716.80 | +80.0% | - | - |